Skip to content

Clinical trials

Terminated Phase 2 Gliosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gliosarcoma Phase: Phase 2 Status: Terminated Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20041
20052
20062
20071
20082
20091
20103
20112
20121
20133
20151
20171
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins4
Duke University2
Ali Altunkaya1
Alliance for Clinical Trials in Oncology1
Annick Desjardins1
Case Comprehensive Cancer Center1
H. Lee Moffitt Cancer Center and Research Institute1
Michael Prados1
Michael Vogelbaum, MD, PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gliosarcoma27
Glioblastoma25
Brain Neoplasms12
Glioma8
Astrocytoma7
Central Nervous System Neoplasms7
Oligodendroglioma4
Ependymoma2
Brain Edema1
Brain Stem Neoplasms1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.